1. Home
  2. PTCT vs AVAL Comparison

PTCT vs AVAL Comparison

Compare PTCT & AVAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • AVAL
  • Stock Information
  • Founded
  • PTCT 1998
  • AVAL 1994
  • Country
  • PTCT United States
  • AVAL Colombia
  • Employees
  • PTCT N/A
  • AVAL N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • AVAL Commercial Banks
  • Sector
  • PTCT Health Care
  • AVAL Finance
  • Exchange
  • PTCT Nasdaq
  • AVAL Nasdaq
  • Market Cap
  • PTCT 5.3B
  • AVAL 4.4B
  • IPO Year
  • PTCT 2013
  • AVAL N/A
  • Fundamental
  • Price
  • PTCT $75.70
  • AVAL $4.18
  • Analyst Decision
  • PTCT Buy
  • AVAL Strong Buy
  • Analyst Count
  • PTCT 17
  • AVAL 1
  • Target Price
  • PTCT $73.24
  • AVAL N/A
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • AVAL 138.7K
  • Earning Date
  • PTCT 11-04-2025
  • AVAL 11-13-2025
  • Dividend Yield
  • PTCT N/A
  • AVAL 2.44%
  • EPS Growth
  • PTCT N/A
  • AVAL N/A
  • EPS
  • PTCT 8.94
  • AVAL N/A
  • Revenue
  • PTCT $1,779,150,000.00
  • AVAL $3,425,872,208.00
  • Revenue This Year
  • PTCT $119.02
  • AVAL $46.54
  • Revenue Next Year
  • PTCT N/A
  • AVAL $8.90
  • P/E Ratio
  • PTCT $8.42
  • AVAL $11.64
  • Revenue Growth
  • PTCT 97.54
  • AVAL 17.60
  • 52 Week Low
  • PTCT $35.95
  • AVAL $1.97
  • 52 Week High
  • PTCT $76.80
  • AVAL $4.50
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 79.67
  • AVAL 60.28
  • Support Level
  • PTCT $69.23
  • AVAL $4.16
  • Resistance Level
  • PTCT $73.98
  • AVAL $4.50
  • Average True Range (ATR)
  • PTCT 2.67
  • AVAL 0.17
  • MACD
  • PTCT 0.40
  • AVAL -0.02
  • Stochastic Oscillator
  • PTCT 89.08
  • AVAL 34.69

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About AVAL Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares)

Grupo Aval Acciones y Valores SA is a Colombian financial services company. Its segments include: Banking Services segment comprises Banking Services, fund management and trust businesses, storage companies and entities that manage low-value payment systems. Merchant Banking segment comprises Financial Sector (trust and brokerage), Gas and Energy Sector (includes natural gas and energy transportation and distribution businesses), Infrastructure Sector (includes road infrastructure projects, construction services, and operation and maintenance), Hotel Sector (includes hospitality services), Agribusiness Sector (includes palm oil, rubber and rice businesses). Pension and Severance Fund Management" segment comprise administrator of pension and severance funds; and Holding segment.

Share on Social Networks: